These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27542974)

  • 1. True Resistant Hypertension Following Observed Drug Ingestion: A Systematic Evaluation.
    Bunker J; Chang CL; Chapman N; Poulter N; Thom S; Thornton-Jones L; Sever P
    J Clin Hypertens (Greenwich); 2017 Mar; 19(3):250-255. PubMed ID: 27542974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is resistant hypertension really resistant?
    Brown MA; Buddle ML; Martin A
    Am J Hypertens; 2001 Dec; 14(12):1263-9. PubMed ID: 11775136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR; Arakawa K
    Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.
    Siddiqui M; Judd EK; Dudenbostel T; Zhang B; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2019 Sep; 74(3):652-659. PubMed ID: 31327263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic.
    Hameed MA; Tebbit L; Jacques N; Thomas M; Dasgupta I
    J Hum Hypertens; 2016 Feb; 30(2):83-9. PubMed ID: 25947275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial.
    Muxfeldt ES; Margallo V; Costa LM; Guimarães G; Cavalcante AH; Azevedo JC; de Souza F; Cardoso CR; Salles GF
    Hypertension; 2015 Apr; 65(4):736-42. PubMed ID: 25601933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote Blood Pressure Monitoring With Social Support for Patients With Hypertension: A Randomized Clinical Trial.
    Mehta SJ; Volpp KG; Troxel AB; Teel J; Reitz CR; Purcell A; Shen H; McNelis K; Snider CK; Asch DA
    JAMA Netw Open; 2024 Jun; 7(6):e2413515. PubMed ID: 38829618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is home blood pressure monitoring useful in the management of patients with resistant hypertension?
    Muxfeldt ES; Barros GS; Viegas BB; Carlos FO; Salles GF
    Am J Hypertens; 2015 Feb; 28(2):190-9. PubMed ID: 25143267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
    Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
    Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence: A Post Hoc Analysis the DENERHTN Study.
    Hamdidouche I; Gosse P; Cremer A; Lorthioir A; Delsart P; Courand PY; Denolle T; Halimi JM; Girerd X; Ormezzano O; Rossignol P; Pereira H; Azizi M;
    Hypertension; 2019 Nov; 74(5):1096-1103. PubMed ID: 31995406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.
    Siddiqui M; Judd EK; Dudenbostel T; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2020 Feb; 75(2):510-515. PubMed ID: 31813346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment).
    Krieger EM; Drager LF; Giorgi DMA; Pereira AC; Barreto-Filho JAS; Nogueira AR; Mill JG; Lotufo PA; Amodeo C; Batista MC; Bodanese LC; Carvalho ACC; Castro I; Chaves H; Costa EAS; Feitosa GS; Franco RJS; Fuchs FD; Guimarães AC; Jardim PC; Machado CA; Magalhães ME; Mion D; Nascimento RM; Nobre F; Nóbrega AC; Ribeiro ALP; Rodrigues-Sobrinho CR; Sanjuliani AF; Teixeira MDCB; Krieger JE;
    Hypertension; 2018 Apr; 71(4):681-690. PubMed ID: 29463627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.